Literature DB >> 16842483

Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors.

P Fornengo1, A Bosio, G Epifani, O Pallisco, A Mancuso, C Pascale.   

Abstract

AIMS: Coronary artery disease (CAD) is the leading cause of death in patients with Type 2 diabetes and is often asymptomatic. Silent myocardial ischaemia (SMI) is frequent in diabetic subjects and is responsible for a late diagnosis of CAD; its early detection is important. There are some data about the prevalence of SMI in Type 2 diabetic patients at high risk for cardiovascular disease, while no data are available in subjects at the onset of diabetes without other cardiovascular risk factors.
METHODS: We screened 274 consecutive patients (mean age 64.3 +/- 8.4 years, 66% male) at the time of diagnosis of Type 2 diabetes; we enrolled 111 subjects without other cardiovascular disease risk factors (dyslipidaemia, hypertension, peripheral vascular disease, retinopathy, microalbuminuria, history of heart disease) and with normal resting electrocardiogram (ECG). Participants performed a maximal ECG exercise protocol and, if positive, underwent coronary angiography.
RESULTS: The ECG exercise test was positive in 19 patients (17.1%); of those 14 (13%) had angiographic coronary disease (one with three-vessel disease, three with two vessels and 10 with one vessel involved). The positive predictive value of the exercise ECG for predicting angiographic coronary disease was 73%.
CONCLUSIONS: The prevalence of SMI was 17% and angiographic coronary disease was found in 13% of middle-aged subjects with new-onset Type 2 diabetes without other cardiovascular risk factors. This prevalence is similar to that observed in studies of subjects with long duration diabetes who have additional cardiovascular risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 16842483     DOI: 10.1111/j.1464-5491.2006.01910.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

Review 1.  Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: a critical review.

Authors:  Ajay Yerramasu; Shreenidhi Venuraju Maggae; Avijit Lahiri; Dhakshinamurthy Vijay Anand
Journal:  J Nucl Cardiol       Date:  2007-12-26       Impact factor: 5.952

2.  Looking after silent coronary artery disease in diabetic patients. When and how?

Authors:  Paul Valensi
Journal:  Endocrine       Date:  2011-10       Impact factor: 3.633

Review 3.  [Erectile dysfunction: indicator of end-organ damage in cardiovascular patients].

Authors:  Magnus Baumhäkel; Nils Schlimmer; Mario T Kratz; Michael Böhm
Journal:  Med Klin (Munich)       Date:  2009-04-15

4.  A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups.

Authors:  N R Bindraban; I G M van Valkengoed; G Mairuhu; R W Koster; F Holleman; J B L Hoekstra; R P Koopmans; K Stronks
Journal:  Eur J Epidemiol       Date:  2007-10-26       Impact factor: 8.082

5.  Silent myocardial ischemia: Current perspectives and future directions.

Authors:  Amany H Ahmed; Kj Shankar; Hossein Eftekhari; Ms Munir; Jillian Robertson; Alan Brewer; Igor V Stupin; S Ward Casscells
Journal:  Exp Clin Cardiol       Date:  2007

6.  Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.

Authors:  Li Jin Pu; Lin Lu; Xue Wei Xu; Rui Yan Zhang; Qi Zhang; Jian Sheng Zhang; Jian Hu; Zheng Kun Yang; Feng Hua Ding; Qiu Jin Chen; Sheng Lou; Jie Shen; Dan Hong Fang; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2006-12-20       Impact factor: 9.951

7.  Factors associated with undiagnosed type 2 diabetes in Germany: results from German Health Interview and Examination Survey for Adults 2008-2011.

Authors:  Yong Du; Jens Baumert; Rebecca Paprott; Andrea Teti; Christin Heidemann; Christa Scheidt-Nave
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.